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Winau et al. (2007) provide convincing evidence that liver stellate cells can be antigen-presenting
cells. This paper raises the following question: what are the roles and importance of diverse anti-
gen-presenting cells in different organs?Investigations in the last several years
indicate that each organ in the body is
capable of regulating antigen process-
ing and presentation. This regulation is
heavily dependent on anatomical and
physiological considerations such as:
patterns of blood flow, barriers to vas-
cular permeability, features of endo-
thelial cells, organization of connective
tissue, expression of adhesion mole-
cules and chemokines, and, of course,
the antigen-presenting cells (APC) of
the tissue. The features of antigen pre-
sentation in the brain, with its tight con-
trol of vascular permeability and its
barriers for lymphocyte entry, is very
different from other organs such as
liver, lungs, or pancreas. Although gen-
eral rules apply, nevertheless each
organ has a unique set of properties
that influence and modulate how the
innate and adaptive cellular systems
interact with microbes and foreign pro-
teins that invade them, and with self
proteins, in case of autoimmunity.
Antigen presentation in each organ is
dependent on the content and activity
of their APC, which include the physio-
logical, or ‘‘professional’’ ones, the
dendritic cells (DC) and macrophages
derived from bone marrow stem cells
by way of the monocyte (see recent re-
view of Reis e Sousa, 2006). APC may
also include the B cells. An issue con-
cerning antigen presentation among
various organs is the extent to which
cells other than the professional APC
handle and present antigens. Such
cells serving as APC may have a pro-
found influence on presentation. This
is the central issue raised in the paper
by Winau et al. (2007). What are poten-
tial ‘‘nonprofessional’’APC?Thesemay
include the major component cells ofthe organ that give it its individuality—
hepatocytes, intestinal epithelial cells,
thymocytes, nerve cells, and so forth.
In general, these cells have a limited
role in initiating T cell activation: most
do not express the molecules required
for presentation including class II
MHC molecules, and the expression
of class I is limiting in many of them.
However, the claim was raised early
on that upon inflammation, and in re-
sponse to cytokines, tissue cells may
aberrantly express MHC molecules,
and in this way present autologous an-
tigens (Bottazzo et al., 1983). The ex-
tent to which this effect takes place
has still to be determined. A second
cellular component in organs is their
stroma with its content of vessels and
connective tissue cells. More attention
to the stromal cellular elements seems
justified as a result of the findings by
Winau et al. (2007).
Winau et al. (2007) examined he-
patic stellate cells or Ito cells (named
for the Japanese anatomist that de-
scribed them). These cells have been
of major interest for those studying
liver pathology (Geerts, 2001) but
have not been the subject of much
attention by the immunology commu-
nity. Ito cells, which comprise about
5%–8% of total cells in the liver, are lo-
cated at a strategic site in the space of
Disse (Figure 1). The liver sinusoid con-
tains a layer of fenestrated endothelial
cells that separate the lumen of the
sinusoid from the hepatocytes. The
space of Disse is situated between
the endothelial layer and the hepato-
cytes, and in it are situated the Ito
cells. On the other hand, Kupffer cells,
which represent in number the major
APC in liver, and DC face the lumen.ImmunitStellate cells are not confined to the
liver but are found in many tissues and
organs where they have been exam-
ined in the context of inflammation
and fibrosis. These cells show a num-
ber of distinguishing features: they
are contractile and phagocytic and
display extensive dendrites and lipid
droplets; they express vimentin, the
intermediate filament protein glial fi-
brillary acidic protein (GFAP), usually
found in neural cells; and they are the
major reservoir for vitamin A in the
body. Importantly in the context of liver
fibrosis, upon their activation stellate
cells produce extracellular matrix pro-
teins including collagen (Geerts, 2001).
Stellate cells will transdifferentiate to
myofibroblasts upon stimulation by cy-
tokines, particularly TGF-b. Myofibro-
blasts show features of smooth muscle
cells expressing a smooth muscle ac-
tin and responding to environmental
signals by releasing extracellular ma-
trix proteins (Powell et al., 1999; Toma-
sek et al., 2002). Stellate cells and
myofibroblasts are important in wound
healing, in control of local blood flow
during inflammation, and in tissue
repair processes. Stellate cells have
been claimed to be of mesenchymal
or endodermal origin, but this needs
to be definitely established (Geerts,
2004; Ogawa et al., 2006)
Winau et al. (2007) carried out an ex-
tensive series of experiments in which
Ito cells isolated from either human or
murine livers were examined for sev-
eral parameters of presentation. Ito
cells displayed CD1d molecules and
were highly effective in activating
NKT cells. NKT cells recognize glyco-
lipid antigens from self proteins and
from microbes and are known to bey 26, January 2007 ª2007 Elsevier Inc. 9
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PreviewsFigure 1. Cells of the Liver Sinusoids
The Ito or stellate cells are located in the space of Disse, which is separated from the lumen by the
fenestrated endothelium. Kupffer cells and DC face the lumen.enriched in liver. Ito cells secreted
IL-15, an important cytokine that regu-
lates NK and NKT cells, and expressed
the costimulatory molecule CD86.
When injected intravenously into CD1d
null mice, Ito cells induced NKT cell
proliferation. Winau went on to show
that not only did Ito cells present anti-
gens via CD1d, but also by class I
and II MHC pathways. Indeed, mice
injected with Ito cells infected with Lis-
teria monocytogenes expressing the
protein ovalbumin developed protec-
tive immunity to Listeria ovalbumin
and activated ovalbumin-specific CD8
T cells. Thus, Ito cells can process in-
tracellular bacteria and are effective
in crosspresentation. This study en-
courages an examination of the poten-
tial role in infection of stellate cells. In
sum, the extensive analysis by Winau
et al. (2007) makes a strong case for
Ito cells as fully capable APC.
A previous study also documented
some antigen-presenting features of
human liver stellate cells (Vin˜as et al.,
2003), although it did not investigate
antigen presentation except in the lim-
ited context of an allogeneic reaction.
Vin˜as et al.’s indicated that human
stellate cells expressed MHC mole-
cules and responded to cytokines by
expressing costimulatory molecules.
What is the relative contribution of
antigen presentation by stellate cells
compared to other cells of the liver pa-10 Immunity 26, January 2007 ª2007 Elsrenchyma such as Kupffer, DC, and
sinusoidal endothelial cells (Figure 1)?
Although Winau et al. (2007) show
that injection of Ito cells plus antigen
are effective in activating T cells, this
approach does not establish the rela-
tive contribution of the various APC,
an issue that is difficult to determine.
Along these lines, a recent report
(Schmeig et al., 2005) indicated that
mice depleted of CD11c+ cells lost
NKT cells in spleen but not in the liver
despite depletion of DC in both
organs. When mice were injected
with chlordonate-containing lipo-
somes, which targets phagocytic cells
and depletes both Kupffer cells and
DC, liver but not spleen NKT cells
were affected. They concluded that
the major APC responsible for activa-
tion of NKT cells differed between liver
and spleen. Because Ito cells, as
Winau et al. (2007) discuss in their
paper, are phagocytic, it needs to be
determined whether the chlordonate
treatment also targeted them. This is
unlikely, given the anatomical situation
of the Ito cells in the space of Disse
separate from the sinusoidal lumen,
which makes them poorly accessible
to circulating macromolecules. Thus,
not unexpectedly, more than one cell
lineage is involved in presentation.
Another important in vivo experiment
from Winau et al. (2007) indicated a
participation of Ito cells in immuneevier Inc.responses of mice genetically modified
to express the influenza hemagglutinin
protein under the GFAP promoter. CD8
T cells directed to the hemagglutinin
proliferated in the liver and clustered
around the GFAP+ Ito cells. Thus, the
evidence is strong that Ito cells can
present antigen in vivo.
In brief, stellate cells need to be con-
sidered as APC in immunological re-
actions in the liver. It now becomes
important to determine the extent of
their participation as well as their im-
portance. This issue also applies to
stellate cells found in numerous tis-
sues and organs where their role has
been mostly examined in terms of fi-
brogenesis, wound healing, or control-
ling blood flow. Regardless of the rela-
tive contribution of stellate cells as
APC, their unique responses as part
of immunological interactions war-
rants a critical examination. APC-T
cell interactions not only result in acti-
vation of T cells, but also of the
presenting cell. In the scenario of the
stellate cell interacting with T cells,
the stellate cell response in terms of
fibrogenesis and control of blood flow
could be of major importance.
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